FONT-SIZE Plus   Neg

RPM Int'l. Q3 Profit Climbs - Quick Facts

RPM International Inc. (RPM) posted a surge in its third-quarter net income attributable to RPM stockholders to $6.62 million from $1.1 million in the year-ago period, with earnings per share jumping to $0.05 from last year's $0.01. On average, 8 analysts polled by Thomson Reuters expected earnings per share of $0.01 for the quarter. Analysts' estimates typically exclude one-time items.

Quarterly net sales totaled $773.64 million, up 14.0% from $678.92 million in the comparable period prior year, whereas 5 analysts estimated revenues of $730.38 million for the quarter.

Chairman and Chief Executive noted, "RPM's operations delivered exceptional performance during our third quarter, with market share gains and improved demand, as nearly all of our business units generated solid sales increases and substantially stronger growth in earnings."

Additionally, the company said it remains confident in its fiscal 2012 initial guidance of earnings per share growth of 10% to 15%, and that fiscal 2013 would be another year of solid sales and earnings growth for RPM.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade RPM now with 
Follow RTT